despit
major
advanc
vaccin
diagnost
therapeut
infect
control
measur
unfinish
agenda
infecti
diseas
remain
global
threat
global
burden
diseas
gbd
studi
report
lower
respiratori
tract
infect
diarrhoeal
diseas
hiv
malaria
four
top
ten
caus
diseas
burden
global
measur
disabilityadjust
life
year
dali
murray
et
al
four
diseas
area
plu
tuberculosi
tb
compris
five
top
eleven
caus
death
worldwid
gbd
mortal
caus
death
collabor
infecti
diseas
gener
larg
econom
burden
fonkwo
antimicrobi
resist
amr
subject
world
health
organ
action
plan
world
health
organ
prioriti
unit
kingdom
uk
anon
european
commiss
us
center
diseas
control
prevent
cdc
anon
project
cost
estim
trillion
year
unadress
anon
research
essenti
improv
evid
base
polici
clinic
practic
uk
research
fund
landscap
sever
nation
intern
award
bodi
invest
preclin
laboratori
scienc
observ
studi
clinic
trial
translat
research
signific
commit
infecti
diseas
research
earlier
research
research
invest
global
health
studi
ebiomedicin
resin
wwwresearchinvestmentsorg
systemat
analys
public
philanthrop
award
total
billion
uk
institut
infecti
diseas
fund
award
infecti
diseas
microbiolog
type
scienc
includ
respiratori
infecti
diseas
research
pneumonia
head
et
al
sepsi
amr
sexuallytransmit
infect
head
et
al
track
research
develop
r
invest
provid
inform
evid
inform
polici
fund
decis
present
updat
systemat
analysi
infecti
diseas
research
award
public
philanthrop
funder
uk
institut
assess
fund
global
measur
mortal
dali
year
live
disabl
yld
across
three
time
point
method
analysi
describ
detail
elsewher
head
et
al
b
c
e
f
head
et
al
b
c
fitchett
et
al
fitchett
et
al
adapt
subsequ
peerreview
public
wwwresearchinvestmentsorgpubl
method
updat
analysi
broadli
similar
systemat
examin
award
data
public
philanthrop
fund
bodi
either
search
databas
inform
public
avail
websit
request
data
directli
search
fund
databas
inform
gather
manual
screen
studi
individu
relev
infecti
diseas
research
exclud
studi
immedi
relev
infecti
diseas
symposium
grant
studi
relat
pure
veterinari
plant
infecti
diseas
includ
anim
health
research
incorpor
clear
zoonot
compon
research
viral
vector
use
relat
noncommunic
diseas
award
led
nonuk
institut
uk
collabor
studi
includ
final
dataset
titl
brief
descriptor
either
abstract
attach
inform
sourc
internet
eg
institut
webpag
clinic
trial
databas
privat
sector
data
avail
analys
detail
therefor
exclud
award
receiv
intern
funder
currenc
convert
uk
pound
use
mean
exchang
rate
year
award
grant
fund
amount
adjust
inflat
report
uk
pound
award
previous
adjust
inflat
level
also
adjust
report
uk
pound
allow
updat
comparison
year
ongo
data
manag
revis
overal
dataset
result
less
studi
chang
previous
report
unfund
studi
exclud
studi
dataset
review
mgh
assign
mani
diseas
categori
appropri
author
vn
nk
provid
support
categoris
process
studi
also
alloc
one
five
categori
along
r
pipelin
preclin
phase
ii
iii
product
develop
public
health
crossdisciplinari
research
introduct
crossdisciplinari
categori
refin
previou
methodolog
prompt
increas
number
type
award
defin
award
contain
signific
compon
studi
cover
two
area
along
r
pipelin
retrospect
appli
new
categori
dataset
owe
resourc
constraint
public
health
research
categori
previous
entitl
implement
oper
research
chang
name
better
reflect
content
categori
involv
chang
studi
categoris
provision
dataset
circul
author
review
comment
check
involv
author
jrf
vn
nk
crosscheck
section
randomlyselect
row
data
disagr
settl
consensu
also
provid
opinion
studi
initi
categoris
prove
difficult
author
mgh
jrf
consid
difficulti
categoris
phase
iiii
studi
product
develop
categori
includ
phase
iv
research
final
dataset
circul
review
author
two
fix
margin
score
calcul
show
level
agreement
type
scienc
categoris
applic
diseas
categori
highlight
high
level
independ
agreement
categoris
process
per
earlier
analysi
categori
antimicrobi
resist
includ
antibacteri
antivir
antifung
resist
refer
diagnost
includ
screen
programm
refer
sexual
transmit
infect
exclud
hiv
defin
categori
neglect
tropic
diseas
categoris
base
infect
focus
http
www
whointneglecteddiseasesdiseasesen
award
defin
global
health
consid
pursu
clear
nonuk
focu
eg
tuberculosi
kenya
ii
focus
diseas
endem
uk
eg
malaria
avail
resin
websit
http
researchinvestmentsorg
aboutthestudystudymethodolog
list
includ
funder
exclud
funder
reason
exclus
list
keyword
use
search
funder
websit
exampl
comment
definit
categoris
stata
softwar
use
data
analysi
global
mortal
dali
data
avail
murray
et
al
lozano
et
al
burden
data
obtain
directli
colleagu
institut
health
metric
evalu
washington
defin
gbd
studi
yld
per
person
sequela
equal
preval
sequela
multipli
disabl
weight
health
state
associ
sequela
yld
diseas
injuri
sum
yld
sequela
associ
diseas
injuri
dali
product
ad
yll
yld
agesexcountri
group
murray
et
al
order
allow
direct
comparison
rel
invest
global
health
metric
across
diseas
area
differ
time
period
metric
develop
show
invest
per
mortal
dalyyld
observ
creat
use
follow
equat
cumul
research
invest
year
time
point
number
death
dali
yld
time
point
number
year
invest
includ
exampl
assess
hiv
mortal
time
point
took
sum
hiv
research
invest
hiv
research
invest
divid
number
death
report
divid
result
number
year
invest
includ
get
invest
per
mortal
observ
metric
use
cumul
invest
divis
number
year
includ
aim
reduc
impact
volatil
annual
research
fund
short
period
time
point
rank
score
invest
metric
develop
infect
across
time
point
infect
rank
order
rel
invest
burden
high
low
assign
score
mean
rank
score
across
time
point
across
mortal
dali
yld
use
illustr
rel
level
invest
mortal
yld
dataset
aggreg
data
avail
diarrhoea
enter
infecti
diseas
lower
respiratori
tract
infect
salmonella
escherichia
coli
shigellosi
vibrio
cholera
campylobact
influenza
pneumonia
proport
estim
compil
use
disaggreg
data
dataset
analysi
analysi
includ
fund
billion
across
award
tabl
volatil
annual
research
fund
though
overal
increas
fig
wellcom
trust
largest
investor
research
fund
studi
total
million
follow
medic
research
council
million
european
commiss
fund
total
invest
across
increas
specif
across
ahead
wellcom
trust
slightli
behind
mrc
supplementari
alongsid
three
funder
nation
institut
health
research
nihr
main
fund
stream
uk
depart
health
biotechnolog
biolog
scienc
research
council
bbsrc
bill
melinda
gate
foundat
combin
contribut
overal
invest
remaind
provid
institut
us
nation
institut
health
nih
uk
govern
depart
uk
research
council
research
chariti
profession
bodi
societi
proport
fund
award
type
scienc
supplementari
fig
show
gradual
increas
invest
public
health
research
slight
declin
preclin
scienc
preclin
scienc
overal
receiv
greatest
invest
billion
follow
public
health
research
million
rel
littl
public
philanthrop
invest
phase
iiii
trial
million
product
develop
studi
million
crossdisciplinari
research
account
small
number
award
overal
greater
proport
fund
million
overal
studi
often
consorti
programm
grant
across
three
time
point
yld
infecti
diseas
broadli
declin
tabl
fig
median
invest
yld
observ
metric
highest
compar
overal
acut
hepat
c
trypanosomiasi
consist
receiv
greatest
rel
invest
respect
tabl
invest
yld
observ
influenza
greatli
increas
compar
pandem
infect
shigellosi
cholera
syphili
gonorrhoea
typic
amongst
receiv
lowest
rel
invest
less
per
yld
observ
rel
level
invest
per
death
dali
yld
infect
combin
consist
increas
time
tabl
fig
compar
mortal
littl
invest
direct
toward
cholera
syphili
pneumonia
vaccineprevent
diseas
diphtheria
measl
pertussi
mostli
rank
poorlyinvest
though
respect
invest
mortal
observ
notic
increas
global
burden
declin
invest
per
dali
observ
metric
tabl
fig
demonstr
similar
find
mortal
metric
pneumonia
appear
poorlyinvest
compar
particularli
highburden
infect
malaria
cholera
syphili
pertussi
also
receiv
littl
fund
acut
hepat
c
african
trypanosomiasi
chlamydia
demonstr
highest
rel
invest
compar
dali
rank
infect
invest
diseas
burden
tabl
describ
hiv
malaria
midrank
diseas
tuberculosi
pneumonia
rank
lower
acut
hepat
c
african
trypanosomiasi
leishmaniasi
top
three
infect
pertussi
cholera
syphili
bottom
three
diphtheria
rank
lowest
three
compar
mortal
dali
whilst
gonorrhoea
rank
lowest
three
compar
yld
identifi
award
infecti
diseas
research
award
uk
institut
across
year
time
period
total
fund
billion
rel
measur
invest
compar
global
mortal
dali
yld
acut
hepat
c
trypanosomiasi
leishmaniasi
rank
highli
whilst
shigellosi
pertussi
cholera
syphili
consist
rank
lowest
tuberculosi
typic
rank
lower
hiv
malaria
pneumonia
appear
receiv
particularli
low
level
invest
compar
mortal
dali
overal
level
invest
median
invest
mortal
dali
yld
observ
increas
compar
previou
time
point
owe
increas
research
invest
decreas
global
burden
infecti
diseas
comparison
global
burden
diseas
develop
associ
metric
demonstr
need
consider
one
measur
burden
pneumonia
diseas
rel
high
mortal
receiv
low
level
research
invest
consid
mortal
dali
rank
higher
consid
lifelong
measur
burden
yld
chlamydia
diseas
low
mortal
rank
highli
compar
invest
mortal
yld
rank
lower
chronic
infect
also
difficult
account
demonstr
high
rank
acut
hepat
c
fulli
take
account
chronic
undiagnos
burden
project
futur
burden
sever
infect
studi
vaccineprevent
measl
pertussi
diphtheria
policymak
need
decid
whether
fund
exampl
oper
research
identifi
improv
deliveri
process
vaccin
invest
heavili
implement
measur
known
effect
expand
work
incorpor
measur
burden
across
differ
time
point
take
account
proport
fund
type
scienc
would
strengthen
model
replic
studi
use
data
countri
noncommunic
diseas
area
would
also
provid
complet
pictur
diseas
adequ
inadequ
invest
work
deciph
impact
predominantli
ukfocus
funder
nihr
global
fund
remit
organis
wellcom
trust
would
also
use
publish
analys
similar
aim
term
consid
invest
burden
consider
nih
fund
suggest
modest
correl
usa
diseas
burden
gillum
et
al
compar
find
analys
australia
mitchel
et
al
norway
king
et
al
show
variabl
correl
depend
upon
chosen
burden
metric
whether
metric
consid
nation
global
burden
thu
policymak
decis
make
extent
target
invest
health
burden
within
countri
much
fund
target
intern
prioriti
decis
driven
extent
remit
exist
fund
agenc
plu
also
exist
research
expertis
uk
diseas
area
ntd
appear
wellfund
rel
global
diseas
burden
may
part
due
previou
ongo
excel
perform
individu
institut
address
area
term
locat
research
invest
activ
uk
demonstr
provid
greater
rel
intern
invest
nation
coloni
tie
may
nation
also
favour
countri
histor
connect
good
reason
common
languag
infrastructur
requir
howev
may
also
mean
countri
neglect
term
receiv
research
invest
could
greatli
benefit
fund
infect
pandem
potenti
remain
inconsist
difficult
project
accur
futur
burden
new
emerg
infecti
diseas
uk
influenza
research
portfolio
arguabl
rel
strong
combin
depart
health
focu
identifi
research
gap
prioriti
area
infecti
diseas
research
network
emerg
larg
ebola
outbreak
west
africa
highlight
littl
research
uk
institut
prior
filovirus
unpublish
analysi
use
resin
data
demonstr
us
nih
funder
track
record
sustain
fund
area
reactiv
effort
across
beyond
greatli
increas
total
research
invest
howev
exampl
ebola
novel
coronavirus
pandem
potenti
show
need
proactiv
approach
term
commiss
capacitystrengthen
carri
research
diseas
potenti
impact
global
health
secur
though
area
commiss
face
signific
challeng
decis
around
resourc
alloc
diseas
erad
may
reflect
interest
specif
donor
highprofil
individu
former
us
presid
jimmi
carter
effort
toward
erad
dracunculiasi
guinea
worm
hopkin
et
al
though
invest
would
consid
implement
rather
research
uk
govern
announc
highprofil
implement
research
invest
collabor
bill
melinda
gate
foundat
advanc
knowledg
infecti
diseas
particularli
malaria
hm
treasuri
id
clearli
factor
beyond
current
project
diseas
burden
influenc
decis
around
research
invest
prioriti
effect
avail
intervent
constitut
best
buy
particular
health
servic
consider
health
inequ
neglect
popul
wiseman
mooney
also
reflect
research
feasibl
likelihood
advanc
knowledg
invest
target
specif
diseas
geograph
area
checklist
health
research
prioriti
set
aim
achiev
maximum
public
health
benefit
suggest
previous
viergev
et
al
data
present
show
rel
scale
invest
compar
diseas
burden
use
inform
commiss
process
research
assess
allevi
impact
diseas
public
health
demonstr
shift
proport
type
scienc
alloc
diseas
area
affect
like
tempor
impact
r
public
health
patient
care
thu
burden
diseas
exampl
gastroenterolog
research
preclin
across
less
half
preclin
rel
equal
sum
money
four
phase
research
may
result
previou
preclin
research
translat
tool
product
knowledg
area
research
pipelin
may
contribut
reduct
global
burden
diseas
observ
enter
infect
level
invest
privat
sector
new
tool
vaccin
therapeut
diagnost
infecti
diseas
import
uncertain
given
low
market
attract
condit
predominantli
affect
lower
incom
middl
incom
countri
though
plausibl
invest
decis
public
philanthrop
privat
sector
made
result
level
interact
sector
exampl
publicpriv
product
develop
partnership
infect
malaria
tb
matern
child
health
also
low
market
attract
lack
fisk
atun
although
progress
made
transpar
report
pharmaceut
biotechnolog
industri
brown
commerci
sensit
mean
difficult
obtain
invest
data
analys
similar
detail
award
includ
low
level
research
invest
syphili
gonorrhoea
remain
head
et
al
term
total
fund
also
compar
diseas
burden
given
increas
level
antibiot
resist
strain
neisseria
gonorrhoea
continu
high
burden
otherwisetreat
infect
seem
area
worthi
greater
focu
uk
research
institut
funder
sepsi
remain
huge
problemat
mani
healthcar
set
research
portfolio
need
increas
reflect
tempor
trend
fund
infecti
diseas
research
note
volatil
exampl
peak
year
fig
partli
due
markedli
increas
contribut
bill
melinda
gate
foundat
year
million
compar
zero
uk
research
invest
result
fluctuat
level
fund
sever
infect
exampl
across
invest
candida
proportion
increas
invest
hpv
decreas
rational
fluctuat
fund
complex
reflect
variou
issu
funder
prioriti
number
applic
receiv
funder
disburs
research
fund
studi
period
research
capac
topic
area
potenti
qualiti
burden
data
avail
studi
sever
limit
describ
previous
addit
limit
analys
exclud
much
infrastructur
fund
funder
invest
quit
heavili
may
underestim
total
invest
infecti
diseas
research
well
contribut
specif
funder
describ
lack
privat
sector
invest
inform
leav
data
gap
analys
taken
account
proport
award
alloc
indirect
estat
cost
distribut
fund
lead
centr
collabor
partner
also
document
categoris
subject
check
least
one
author
reduc
impact
observ
error
analysi
also
vulner
effect
chang
methodolog
gbd
studi
also
uncertainti
diseas
estim
calcul
gbd
analys
public
philanthrop
research
fund
infecti
diseas
increas
time
period
compar
previou
year
greater
mean
median
award
amount
indic
shift
toward
fund
award
type
consortia
programm
grant
measur
invest
global
burden
diseas
highlight
area
influenza
trypanosomiasi
uk
rel
strong
invest
probabl
research
strength
area
sepsi
pneumonia
syphili
gonorrhoea
remain
area
rel
underinvest
consid
fund
organis
policymak
coordin
effort
across
global
health
commun
must
consid
research
invest
emerg
infecti
diseas
pathogen
pandem
potenti
demonstr
potenti
inequ
alloc
invest
diseas
burden
analys
resin
studi
contribut
prioriti
set
funder
inform
strategi
policymak
govern
depart
research
institut
fund
sourc
studi
ethic
statement
requir
work
mgh
jrf
design
studi
mgh
wrote
submiss
edit
author
mgh
jrf
nk
vn
collect
categoris
data
ah
ra
provid
commentari
dataset
interpret
result
author
gave
comment
draft
final
version
manuscript
